Heptapeptide Stimulation of Sexual Function
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for sexual dysfunctions not caused by organic disorders or diseases are inadequate, and there is a need for effective and safe medicinal agents that can stimulate genital, sexual, and reproductive functions.
Innovation Solution
A pharmaceutical composition comprising a heptapeptide of the formula Thr-Lys-Pro-Arg-Pro-Gly-Pro is used to stimulate genital, sexual, and reproductive functions, exhibiting a broader spectrum of action that includes optimizing intellectual and cognitive functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (hormonal therapy, antibiotics, desensitizing agents) are used for sexual dysfunction, then comprehensive long-term treatment is provided, but the treatments are inadequate and lack effectiveness for non-organic sexual dysfunctions
Solution Approach 1:
The patent extracts and utilizes endogenous regulatory peptides (specifically oxytocin and tuftsin) that naturally regulate sexual and reproductive functions, removing the need for complex external hormonal treatments and antibiotics. This extraction of natural regulatory mechanisms provides a simpler, more effective treatment approach for non-organic sexual dysfunctions.
Solution Approach 2:
The invention employs endogenous peptides that the body already produces to regulate its own sexual and reproductive functions. By stimulating the body's own regulatory systems rather than introducing external hormones or medications, the treatment achieves effectiveness while maintaining simplicity and avoiding the need for comprehensive long-term complex regimens.
2Adaptability or versatility
If stress and ecological factors are addressed, then the underlying causes of sexual dysfunction are targeted, but the complexity of modern life factors makes treatment difficult
Solution Approach 1:
The patent segments the complex problem of sexual dysfunction caused by multiple stress and ecological factors into a targeted biological mechanism. Instead of attempting to address all life factors simultaneously, the invention focuses on the specific endogenous peptide pathways (oxytocin and tuftsin) that are disrupted by these factors, providing an adaptable treatment that addresses the root cause without requiring complex multi-factor intervention.
Solution Approach 2:
The endogenous peptides used in this invention have universal adaptability to various stress and ecological factors that cause sexual dysfunction. Oxytocin and tuftsin regulate multiple aspects of sexual and reproductive function across different stress conditions, providing a versatile treatment approach that works regardless of the specific combination of modern life factors affecting the patient.
Data Source
AI summary
The invention relates to a novel agent having an influence on the genital, sexual and reproductive function of mammals and human beings. More specifically, the invention relates to the use of a heptapeptide of the general formula (I) Thr-Lys-Pro-Arg-Pro-Gly-Pro as a stimulator of the genital, sexual and reproductive function of mammals and human beings. The invention widens the range of agents available for stimulating the genital, sexual and reproductive function of mammals and human beings.